Lifespin GmbH, founded in 2017 and headquartered in Germany, is a dynamic player in the intersection of Health Care and Information Technology. The company's slogan, "Lifespin GmbH creates AI-based health testing platform for patient samples with metabolomics data mapping," reflects its mission to harness the power of AI and data analytics in healthcare.
Lifespin's innovative platform leverages advanced AI technology to analyze quantitative metabolic data from patient samples, transforming it into actionable health insights. This metabolomics mapping expertise positions Lifespin as a valuable partner across pharmaceutical, research, and clinical sectors. The platform's applications, ranging from diagnostics and personalized medicine to patient stratification and drug discovery, hold significant promise for enhancing healthcare outcomes.
The company's last known investment was a €2.50M Convertible Note on 13 December 2021, backed by Wieland Capital, illustrating strong investor confidence in its vision and technology.